Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?

Purpose The detection rate for significant prostate cancer of mMRI/TRUS fusion targeted biopsy versus saturation prostate biopsy was prospectively evaluated in men enrolled in active surveillance (AS) protocol. Methods From May 2013 to January 2015, 40 men aged 66 years (median) with very low-risk P...

Full description

Saved in:
Bibliographic Details
Published in:World journal of urology 2016-09, Vol.34 (9), p.1249-1253
Main Authors: Pepe, Pietro, Garufi, Antonio, Priolo, Giandomenico, Pennisi, Michele
Format: Article
Language:English
Subjects:
Aged
Humans
Image-Guided Biopsy
Magnetic Resonance Imaging, Interventional
Male
Medicine
Medicine & Public Health
Middle Aged
Nephrology
Oncology
Original Article
Prospective Studies
Prostate - diagnostic imaging
Prostate - pathology
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - pathology
Prostatic Neoplasms - therapy
Rectum
Ultrasonography, Interventional - methods
Urology
Watchful Waiting
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose The detection rate for significant prostate cancer of mMRI/TRUS fusion targeted biopsy versus saturation prostate biopsy was prospectively evaluated in men enrolled in active surveillance (AS) protocol. Methods From May 2013 to January 2015, 40 men aged 66 years (median) with very low-risk PCa were enrolled in an AS protocol, and eligible criteria were: life expectancy greater than 10 years, cT1C, PSA below 10 ng/ml, PSA density 
ISSN:0724-4983
1433-8726
DOI:10.1007/s00345-015-1749-3